BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25961724)

  • 41. Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study.
    Chiang SF; Kan CY; Hsiao YC; Tang R; Hsieh LL; Chiang JM; Tsai WS; Yeh CY; Hsieh PS; Liang Y; Chen JS; Yu JS
    Dis Markers; 2015; 2015():874054. PubMed ID: 26494939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
    Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
    Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer.
    Feng YH; Su YC; Lin SF; Lin PR; Wu CL; Tung CL; Li CF; Shieh GS; Shiau AL
    BMC Cancer; 2019 Aug; 19(1):791. PubMed ID: 31399076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteopontin induced by macrophages contribute to metachronous liver metastases in colorectal cancer.
    Imano M; Okuno K; Itoh T; Satou T; Ishimaru E; Yasuda T; Hida J; Imamoto H; Takeyama Y; Shiozaki H
    Am Surg; 2011 Nov; 77(11):1515-20. PubMed ID: 22196667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.
    Standal T; Hjorth-Hansen H; Rasmussen T; Dahl IM; Lenhoff S; Brenne AT; Seidel C; Baykov V; Waage A; Børset M; Sundan A; Hjertner O
    Haematologica; 2004 Feb; 89(2):174-82. PubMed ID: 15003892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential membranous E-cadherin expression, cell proliferation and O-GlcNAcylation between primary and metastatic nodal lesion in colorectal cancer.
    Jang TJ
    Pathol Res Pract; 2016 Feb; 212(2):113-9. PubMed ID: 26724145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases.
    Mole DJ; O'Neill C; Hamilton P; Olabi B; Robinson V; Williams L; Diamond T; El-Tanani M; Campbell FC
    Br J Cancer; 2011 Mar; 104(6):1007-12. PubMed ID: 21343932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma osteopontin is an independent prognostic marker for head and neck cancers.
    Petrik D; Lavori PW; Cao H; Zhu Y; Wong P; Christofferson E; Kaplan MJ; Pinto HA; Sutphin P; Koong AC; Giaccia AJ; Le QT
    J Clin Oncol; 2006 Nov; 24(33):5291-7. PubMed ID: 17114663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of osteopontin expression on the metastatic growth of CC531 rat colorectal carcinoma cells in rat liver.
    Uhlmann ME; Georges RB; Boleij A; Eyol E; Kubarenko A; Adwan H; Berger MR
    Cancer Gene Ther; 2011 Nov; 18(11):795-805. PubMed ID: 21852811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
    Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
    Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension.
    Rosenberg M; Meyer FJ; Gruenig E; Lutz M; Lossnitzer D; Wipplinger R; Katus HA; Frey N
    Eur J Clin Invest; 2012 Sep; 42(9):933-42. PubMed ID: 22500728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer.
    Li T; Guo H; Song Y; Zhao X; Shi Y; Lu Y; Hu S; Nie Y; Fan D; Wu K
    Mol Cancer; 2014 Dec; 13():263. PubMed ID: 25496021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy.
    Snitcovsky I; Leitão GM; Pasini FS; Brunialti KC; Mangone FR; Maistro S; de Castro G; Villar RC; Federico MH
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):807-11. PubMed ID: 19687403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.
    Singhal H; Bautista DS; Tonkin KS; O'Malley FP; Tuck AB; Chambers AF; Harris JF
    Clin Cancer Res; 1997 Apr; 3(4):605-11. PubMed ID: 9815727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteopontin (OPN/SPP1), a Mediator of Tumor Progression, Is Regulated by the Mesenchymal Transcription Factor Slug/SNAI2 in Colorectal Cancer (CRC).
    Amilca-Seba K; Tan TZ; Thiery JP; Louadj L; Thouroude S; Bouygues A; Sabbah M; Larsen AK; Denis JA
    Cells; 2022 May; 11(11):. PubMed ID: 35681502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications.
    Amilca-Seba K; Sabbah M; Larsen AK; Denis JA
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection.
    Zhao L; Li T; Wang Y; Pan Y; Ning H; Hui X; Xie H; Wang J; Han Y; Liu Z; Fan D
    Int J Clin Pract; 2008 Jul; 62(7):1056-62. PubMed ID: 17537188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.
    Le QT; Sutphin PD; Raychaudhuri S; Yu SC; Terris DJ; Lin HS; Lum B; Pinto HA; Koong AC; Giaccia AJ
    Clin Cancer Res; 2003 Jan; 9(1):59-67. PubMed ID: 12538452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The prognostic significance of preoperative plasma level of osteopontin in combination with intercellular adhesion molecule-1 for patients with hepatocellular carcinoma].
    Zhang H; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):985-8. PubMed ID: 16194354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.